Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are expecting strong results driven by the continued https://tomasfgrb931250.vblogetin.com/42833999/analyzing-eli-lilly-s-q3-results